Free Newsletter
Genentech's stock hop
Free newsletter via e-mail
Tools
The price of Genentech stock went up yesterday afternoon, closing at $83.14 after climbing 1.9 percent. Perhaps we already are seeing a pharma comeback as the Pfizer-Wyeth merger progresses, and perhaps Genentech stock prices will continue to rise until Roche--or someone else--makes it an offer it cannot refuse. Report.
More stories about Genentech
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: